Krome, A.K.; Becker, T.; Kehraus, S.; Schiefer, A.; Steinebach, C.; Aden, T.; Frohberger, S.J.; López Mármol, Á.; Kapote, D.; Jansen, R.;
et al. Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A. Pharmaceutics 2020, 12, 1105.
https://doi.org/10.3390/pharmaceutics12111105
AMA Style
Krome AK, Becker T, Kehraus S, Schiefer A, Steinebach C, Aden T, Frohberger SJ, López Mármol Á, Kapote D, Jansen R,
et al. Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A. Pharmaceutics. 2020; 12(11):1105.
https://doi.org/10.3390/pharmaceutics12111105
Chicago/Turabian Style
Krome, Anna K., Tim Becker, Stefan Kehraus, Andrea Schiefer, Christian Steinebach, Tilman Aden, Stefan J. Frohberger, Álvaro López Mármol, Dnyaneshwar Kapote, Rolf Jansen,
and et al. 2020. "Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A" Pharmaceutics 12, no. 11: 1105.
https://doi.org/10.3390/pharmaceutics12111105
APA Style
Krome, A. K., Becker, T., Kehraus, S., Schiefer, A., Steinebach, C., Aden, T., Frohberger, S. J., López Mármol, Á., Kapote, D., Jansen, R., Chaverra-Muñoz, L., Hübner, M. P., Pfarr, K., Hesterkamp, T., Stadler, M., Gütschow, M., König, G. M., Hoerauf, A., & Wagner, K. G.
(2020). Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A. Pharmaceutics, 12(11), 1105.
https://doi.org/10.3390/pharmaceutics12111105